American Society of Hirudotherapy

Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1/Caspase-3 and PI3K/AKT/mTOR Pathway

Basic science / preclinical published in CNS Neurosci Ther (2025)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportSalivary PharmacologyDrug DevelopmentWu S et al. · CNS neuroscience & therapeutics, 2025

Abstract

BACKGROUND: Glioblastoma (GBM) represents the most lethal form of high-grade glioma, with current therapeutic options proving largely ineffective. Consequently, there is an urgent need for novel treatment strategies. Recent studies have indicated that the medicinal leech exhibits notable anticancer properties. However, the precise mechanisms underlying these effects remain to be elucidated. METHODS: To investigate the impact of leech drug-containing serum (LDS) on the proliferation, migration, and invasion of GBM cells, a series of assays including CCK-8, ethynyl deoxyuridine (EdU), colony formation, scratch, and transwell assays were employed. Additionally, the apoptosis and autophagy of GBM cells were analyzed using flow cytometry, monodansylcadaverine staining and the immunofluorescence assay. Transcriptomic sequencing of the cells was conducted to identify differentially expressed genes. In vivo, anticancer activity was assessed by developing tumor xenograft models. Western blot analysis was utilized to identify proteins associated with apoptosis and autophagy. RESULTS: Leech drug-containing serum (LDS) significantly inhibited proliferation, migration, and invasion. Furthermore, it induced autophagy and apoptosis in GBM. Differential gene enrichment analysis and pathway validation indicated that LDS exerts anti-GBM effects by modulating the PI3K/AKT pathway. Leech extracts effectively inhibit the growth of GBM in a subcutaneous xenograft tumor model. CONCLUSION: The leech-derived compounds may induce apoptosis and autophagy in GBM by modulating the PI3K/AKT/mTOR signaling pathway, without eliciting significant adverse effects, thereby presenting itself as a promising therapeutic agent.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsGlioblastomaHumansApoptosisAutophagyTOR Serine-Threonine KinasesCell Line, TumorSignal TransductionProto-Oncogene Proteins c-aktMiceProtein Serine-Threonine KinasesLeechesCaspase 3Phosphatidylinositol 3-KinasesMice, NudeBrain NeoplasmsXenograft Model Antitumor AssaysCell ProliferationCell MovementMice, Inbred BALB C

Summary

Treating glioblastoma cells with leech drug-containing serum reduced their proliferation, migration and invasion while triggering apoptosis and autophagy; leech extract also inhibited tumor growth in a subcutaneous xenograft model, with anti-GBM effects potentially involving the PI3K/AKT/mTOR and SGK1/Caspase-3 pathways, without significant adverse effects.

Why This Matters for Hirudotherapy

This study investigated the effects of leech drug-containing serum (LDS) on glioblastoma (GBM) using in vitro assays (CCK-8, EdU, colony formation, scratch, transwell, flow cytometry, immunofluorescence) and an in vivo subcutaneous xenograft tumor model. LDS significantly inhibited proliferation, migration, and invasion while inducing autophagy and apoptosis, with transcriptomic and pathway analyses implicating PI3K/AKT/mTOR signaling. The leech extract also effectively inhibited GBM growth in the xenograft model. The study explores anticancer properties of a medicinal leech preparation, investigating leech-derived compounds as potential therapeutic agents. Caveat: this is preclinical work using cell lines and xenograft models; no human data is presented, and the abstract does not specify the leech species, preparation details, or the xenograft animal species.

Citation

Reference (Vancouver style)

Wu S, Zhou Y, Pei Z, Wang Y, Zhang Z. Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1/Caspase-3 and PI3K/AKT/mTOR Pathway. CNS Neurosci Ther. 2025;31(12):e70683. doi:10.1002/cns.70683. PMID: 41326907

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.